Proviron - Zyvex Pharmaceuticals
Proviron - Mesterolone for SHBG Binding, Libido, and On-Cycle Testosterone Enhancement
Proviron by Zyvex Pharmaceuticals contains Mesterolone at 25 mg per tablet. Mesterolone is a DHT-derived oral anabolic steroid with a pharmacological profile unlike any other compound in the steroid category. It does not produce significant direct anabolic effects at typical doses, does not aromatize to estrogen, and - critically - is not 17-alpha alkylated, making it the only commonly used oral anabolic steroid that carries no hepatotoxicity. Proviron is used not as a primary muscle-building compound but as cycle support: it binds to sex hormone binding globulin (SHBG) with high affinity, displacing testosterone and other steroids from the protein that would otherwise render them inactive, thereby increasing the amount of free (biologically active) hormone in circulation. At 25-75 mg/day, Proviron measurably increases free testosterone levels on a testosterone cycle without adding any additional suppression or estrogenic burden.
Proviron's secondary effects - improved libido, a mild anti-estrogenic effect through androgen receptor competition, and a hardening effect on the physique - make it a practical addition to a wide range of cycles. It is used throughout the cycle from the first week through to the final pin, and it does not require post-cycle therapy of its own because its HPTA suppression at standard doses is minimal. These properties position Proviron as one of the most versatile on-cycle support compounds available: it enhances the effectiveness of whatever other compounds are in the cycle, keeps libido stable during suppressive cycles, and contributes a modest hardening effect with no meaningful negative hormonal consequences for the user who discontinues it at cycle end.
About the Compound
Mesterolone was developed by Schering and introduced in 1967 under the Proviron brand name, primarily for the treatment of male hypogonadism, androgen deficiency, and male infertility. It is one of the oldest anabolic steroids in continuous clinical use. Its medical longevity is partly explained by its unique safety profile: unlike Dianabol, Anavar, and Winstrol, Mesterolone is not 17-alpha alkylated. This structural difference means it cannot pass through the liver in sufficient quantity when taken orally through standard alkylation chemistry. Instead, Mesterolone uses a different modification (1-methylation) that provides oral bioavailability while avoiding the hepatotoxic alkylation required by other oral steroids. The result is an oral anabolic compound with no clinically meaningful liver stress - a distinction it shares with no other commonly used oral anabolic steroid.
The anabolic rating of Mesterolone is 100-150 versus testosterone's 100, but this does not translate to meaningful muscle building in practice. The compound undergoes rapid inactivation in muscle tissue by the 3-alpha hydroxysteroid dehydrogenase enzyme, which converts the active androgen to an inactive metabolite before it can exert significant anabolic activity in muscle. What persists is its activity in tissues that do not express this enzyme - androgenic activity in sebaceous glands and hair follicles, strong SHBG binding, and central nervous system effects contributing to libido and mood. The SHBG binding is the primary pharmacological mechanism driving Proviron's cycle support value: Mesterolone has one of the highest SHBG affinity constants of any anabolic steroid, meaning it displaces testosterone and other active steroids from SHBG and increases their free fraction in the bloodstream.
Effects and Benefits
Proviron does not replace a primary anabolic compound but multiplies the effectiveness of whatever compounds are already in the cycle. Its value is support-oriented rather than mass-building.
- Increased free testosterone via SHBG binding - SHBG binds testosterone and renders it biologically inactive. On a typical steroid cycle, a portion of exogenous testosterone is still bound by SHBG and unavailable for androgen receptor binding in muscle tissue. Proviron binds SHBG with high affinity, displacing testosterone and increasing the free fraction. At 50 mg/day, this effect is measurable in bloodwork as an increase in free testosterone without any change in total testosterone dose. The practical result is enhanced effectiveness of whatever testosterone dose is being used.
- Libido and sexual function support - Suppressive steroid cycles commonly reduce libido through mechanisms including elevated estrogen, prolactin from Nandrolone compounds, and simple hormonal disruption of the feedback axis. Proviron addresses the androgenic component of libido directly by providing DHT-like androgenic stimulation at tissues involved in sexual function. Users running Deca or other suppressive compounds frequently add Proviron specifically to maintain libido when other compounds are working against it.
- Mild anti-estrogenic effect - Proviron does not inhibit the aromatase enzyme meaningfully and is not a true aromatase inhibitor. However, it competes with estrogen for androgen receptor binding at tissues where DHT is active, producing a mild anti-estrogenic effect through receptor displacement rather than enzyme inhibition. This contributes to a drier, harder appearance - particularly noticeable at body fat levels below 12-15% - and modestly reduces water retention on testosterone-based cycles. It is not a replacement for an AI on a testosterone cycle but provides a complementary effect.
- Physique hardening - The combination of SHBG binding, mild anti-estrogenic activity, and direct androgenic activity at tissues including sebaceous glands contributes to the hardened, dense appearance that users on Proviron describe during cutting phases. This effect is most pronounced when body fat is already low and water retention is the remaining barrier to a harder look.
- No hepatotoxicity - Because Mesterolone is not 17-alpha alkylated, it does not stress the liver through the mechanism that makes other oral anabolic steroids hepatotoxic. Users who need to run an oral support compound for the full duration of a 12-16 week cycle without the liver rest windows required by Dianabol or Anavar can use Proviron throughout the entire cycle without concern for liver enzyme elevation.
Proviron does not require post-cycle therapy of its own when used at 25-75 mg/day. At standard support doses, Mesterolone causes minimal HPTA suppression - clinical data from therapeutic use shows it does not meaningfully suppress LH or FSH at 25-50 mg/day. Users can discontinue Proviron at the end of the cycle without a separate taper or PCT for the Proviron itself. The PCT required after the cycle addresses suppression from the primary anabolic compounds (testosterone, Nandrolone, etc.), not from Proviron. Proviron should not be used as a substitute for PCT - it does not stimulate LH or FSH production and cannot replace Nolvadex or Clomid for HPTA recovery.
Dosing and Cycle Use
Standard Dose
The standard on-cycle support dose is 25-50 mg/day (1-2 tablets). At 25 mg/day, SHBG binding effects are present but modest. At 50 mg/day, the SHBG binding effect is meaningful in bloodwork and the libido and anti-estrogenic contributions are more pronounced. Some users run 75 mg/day (3 tablets) for a more aggressive anti-estrogenic or hardening effect during contest preparation. Doses above 100 mg/day increase androgenic side effects substantially and are generally not necessary for cycle support purposes.
Timing and Cycle Use
Proviron is taken daily with food, split into one or two doses to account for its ~12-hour half-life. A single 50 mg dose in the morning is common and practical. Splitting into 25 mg morning and 25 mg evening maintains more consistent blood levels. Proviron is typically run throughout the entire cycle - from week 1 through to the final injection or last tablet of the primary compounds - because its support functions (libido, SHBG binding, anti-estrogenic effect) are most valuable while other suppressive compounds are active. It is discontinued when the primary compounds end, as there is no need to taper or continue it into PCT.
Cycle Length
Proviron can be run for the full duration of any cycle without the time limits that apply to 17-AA oral steroids. On a 12-week or 14-week injectable cycle, Proviron runs for all 12-14 weeks. This is a practical advantage over Anavar or Dianabol as a support oral, where the 4-6 week hepatotoxicity limit means the compound cannot be maintained throughout a longer cycle.
Use Cases
| Use Case | Cycle Setup | Notes |
|---|---|---|
| On-cycle SHBG support with testosterone | Proviron 50 mg/day throughout any testosterone cycle | Increases free testosterone without raising the total testosterone dose. Adds libido support and mild estrogen management. Particularly useful on high-testosterone cycles where SHBG binding is limiting free hormone availability. |
| Libido support on Deca or NPP cycles | Proviron 50 mg/day throughout Nandrolone-containing cycle | Deca and NPP suppress DHT and libido through progesterone activity and HPG suppression. Proviron's DHT-like action directly counteracts the libido suppression from Nandrolone at the receptor level. |
| Cutting cycle hardening | Proviron 50-75 mg/day + Testosterone Propionate 300 mg/wk + Masteron 100 300 mg/wk, 10-12 weeks | All-DHT cycle with dual hardening compounds. Proviron adds SHBG binding and oral androgen support; Masteron adds injectable androgenic hardening. AI at low dose for testosterone estrogen only. |
| Lean bulk anti-estrogen support | Proviron 25-50 mg/day alongside Testosterone Enanthate 400-500 mg/wk, 12-14 weeks | Supplements AI management by adding a complementary anti-estrogenic mechanism without the risk of estrogen crash from aggressive AI dosing. Reduces total AI dose needed while maintaining estrogen control. |
| PCT libido bridge (alongside Nolvadex) | Proviron 25 mg/day during PCT weeks 1-4 alongside Nolvadex 40/20 mg taper | Not a standalone PCT. Used alongside standard Nolvadex PCT to maintain androgenic libido support while Nolvadex stimulates LH/FSH recovery. Proviron is discontinued when PCT ends; Nolvadex drives the actual HPTA recovery. |
Side Effects
| Side Effect | Background | Management |
|---|---|---|
| Hair loss (androgenic) | Mesterolone is a DHT derivative with activity at the scalp's androgen receptors. In genetically predisposed individuals, Proviron at 50-75 mg/day can accelerate androgenic hair thinning. The risk is lower than Masteron or Winstrol at equivalent doses because Proviron is partially inactivated in muscle, but the scalp does not have the same inactivating enzyme profile. Finasteride is not effective as Mesterolone is already a DHT derivative. | Nizoral shampoo for maintenance. Dose reduction if thinning is observed. Finasteride is not useful - Mesterolone does not convert via 5-alpha reductase. |
| Acne | DHT activity at sebaceous glands can cause acne in sensitive users, particularly at 75+ mg/day. At 25-50 mg/day, acne is uncommon and less pronounced than from testosterone or Trenbolone at equivalent androgenic doses. | Standard skincare. Reduce dose if persistent. Less aggressive management needed than testosterone-based cycles. |
| Mild HPTA suppression | At 25-50 mg/day, Proviron causes minimal LH/FSH suppression in clinical data. At 75-100 mg/day, suppression becomes more meaningful. At standard cycle support doses, this is not a clinically significant concern and does not require additional PCT management when Proviron alone is discontinued. | Use at standard support doses of 25-50 mg/day. Do not exceed 75 mg/day unnecessarily. No additional PCT needed for Proviron alone at these doses. |
| Lipid changes | Mesterolone produces mild unfavorable lipid changes - HDL reduction and LDL increase - consistent with androgenic steroid use. The magnitude is less severe than oral 17-AA steroids because the absence of 17-alkylation reduces the first-pass liver impact on lipid metabolism. | Lipid panel bloodwork. Fish oil supplementation. Less aggressive monitoring needed than with 17-AA oral compounds. |
| No estrogenic side effects | Mesterolone does not aromatize - there is no gynecomastia risk or estrogen-driven water retention from Proviron itself. Its mild anti-estrogenic effect through receptor competition is an additional benefit rather than a concern. | No estrogen management needed for Proviron. AI management directed at other cycle compounds only. |
Proviron vs Masteron
| Factor | Proviron (Mesterolone 25 mg/tab) | Masteron (Drostanolone) |
|---|---|---|
| Administration | Oral tablet - daily dosing | Injectable - EOD (Propionate) or twice-weekly (Enanthate) |
| Hepatotoxicity | None - not 17-alpha alkylated | None - injectable |
| SHBG binding | High - primary mechanism for freeing active testosterone | Moderate - less potent SHBG binder than Proviron |
| Anabolic effect | Minimal - inactivated in muscle tissue | Moderate - meaningful lean mass at 300-400 mg/week |
| Anti-estrogenic effect | Mild - via androgen receptor competition | Moderate - stronger receptor competition than Proviron |
| Hardening effect | Mild to moderate | Stronger, more visible at low body fat |
| Best role | Oral cycle support - SHBG binding, libido, throughout long cycles | Primary DHT compound in cutting stacks - hardening, anti-estrogen, lean mass |
| Use together? | Yes - Proviron and Masteron are complementary: Proviron provides oral SHBG binding and libido support; Masteron provides injectable androgenic hardening and stronger anti-estrogenic effect | |
Frequently Asked Questions
What is Proviron (Mesterolone) and what does it do on a steroid cycle?
Proviron is the brand name for Mesterolone, a dihydrotestosterone (DHT) derivative taken orally as a 25 mg tablet. Unlike most anabolic steroids, Proviron is not used primarily for building muscle. Its main role on a cycle is to bind sex hormone-binding globulin (SHBG) - a protein that attaches to testosterone and renders it biologically inactive. By occupying SHBG binding sites, Proviron frees a greater proportion of the testosterone already in circulation, increasing the amount of active hormone available to tissues. Secondary effects include mild androgenic activity (supporting libido and mood), mild anti-estrogenic activity through estrogen receptor competition rather than aromatase inhibition, and a cosmetic hardening effect at low body fat. Proviron does not convert to estrogen, is not hepatotoxic, and is typically run throughout the entire cycle at 25-75 mg per day.
How does Proviron increase free testosterone - what is the SHBG binding mechanism?
Testosterone circulates in three forms: free (roughly 2-3%), loosely bound to albumin (roughly 40%), and tightly bound to SHBG (roughly 57%). Only free testosterone and albumin-bound testosterone are biologically active. SHBG-bound testosterone cannot bind to androgen receptors. Mesterolone has an exceptionally high binding affinity for SHBG - higher than testosterone itself. When Proviron is present, it preferentially occupies SHBG binding sites, leaving more testosterone in the free or albumin-bound fraction. At 50-75 mg per day alongside a typical testosterone dose, this shift in the free:bound ratio produces a meaningful increase in biologically active testosterone without changing the total testosterone dose at all. This is why Proviron is added to cycles even when testosterone is already present - it amplifies the effective dose of whatever testosterone is already being used.
Is Proviron hepatotoxic? Can it damage the liver?
No. Proviron (Mesterolone) is not hepatotoxic and does not require liver protection or rest windows during use. This is its most clinically significant property among oral anabolic agents. Nearly all other oral anabolic steroids - Dianabol, Anadrol, Winstrol, Turinabol, Anavar - are 17-alpha alkylated (17-AA), a structural modification that makes them orally bioavailable by resisting first-pass liver metabolism. This same modification is what causes hepatotoxicity. Mesterolone achieves oral bioavailability through a different structural feature: a 1-methyl group that slows hepatic breakdown without the liver-damaging 17-AA modification. The result is a genuinely liver-safe oral steroid - the only common one in this category. Proviron can be run for the full length of a 12-16 week cycle without liver enzyme elevation concerns that apply to other oral compounds.
What is the correct Proviron dose and how should it be taken?
The standard Proviron dose is 25-75 mg per day. At 25 mg daily (one tablet), SHBG binding and libido support are mild but present. At 50 mg daily (two tablets), the SHBG binding effect is more pronounced and this is the most commonly used dose for on-cycle support. At 75 mg daily (three tablets), the anti-estrogenic and hardening effects are stronger, making it useful during cutting phases or contest preparation. Some experienced users run 100 mg per day but diminishing returns apply beyond 75 mg for most purposes. Proviron has a half-life of approximately 12 hours, so once-daily dosing is functional but twice-daily dosing (splitting the total dose morning and evening with food) produces more stable blood levels throughout the day. It is taken with meals to support absorption. Proviron is run throughout the entire cycle - there is no need for a 4-6 week limit as applies to hepatotoxic orals.
Does Proviron require PCT after a cycle?
Proviron itself does not require its own PCT. At standard doses of 25-75 mg per day, Mesterolone causes minimal suppression of the hypothalamic-pituitary-testicular axis (HPTA). Unlike anabolic steroids that significantly suppress LH and FSH, Proviron at these doses does not produce the degree of suppression that requires SERMs or other PCT agents to reverse. PCT is still required for the other compounds used in the cycle - testosterone, nandrolone, trenbolone, and any other suppressive steroids all require standard PCT. Proviron is simply discontinued along with the rest of the cycle. It does not extend PCT requirements and does not need to be tapered. One legitimate use of Proviron during PCT itself is as a libido support adjunct alongside Nolvadex or Clomid - it can help maintain libido and sense of well-being during the recovery period. However, Proviron alone is NOT a PCT substitute. It does not stimulate LH or FSH production and cannot restore natural testosterone production on its own.
Can Proviron be used as an aromatase inhibitor (AI) to control estrogen?
No, not effectively. Proviron has mild anti-estrogenic activity but it is not an aromatase inhibitor. It does not block the aromatase enzyme that converts testosterone to estradiol. Its anti-estrogenic effect comes from two secondary mechanisms: competition with estrogen at estrogen receptors (partial receptor antagonism, similar to how Nolvadex works at breast tissue but weaker and systemic) and displacement of estrogen from SHBG, which can moderately lower free estradiol. These effects are too weak and too indirect to replace a real AI such as Arimidex or Aromasin on moderate-to-high testosterone doses. On a 400-500 mg/week testosterone cycle, Proviron alone will not adequately manage estrogen. On a very low testosterone dose (100-200 mg/week TRT range), Proviron at 50-75 mg/day may be sufficient to prevent estrogen-related side effects in some users, but this varies significantly by individual aromatase activity. If gynecomastia is a concern or bloodwork shows elevated estradiol, a proper AI is required.
What is the best use case for Proviron on a cycle?
Proviron performs best as a cycle support compound added to testosterone-based stacks where SHBG is elevated or libido is a concern. The single most effective use is on cycles that include 19-nor compounds (Deca Durabolin, NPP) - these compounds are notorious for causing libido suppression and sexual dysfunction ("Deca dick") during the cycle. Proviron at 50 mg per day alongside the testosterone base counteracts this effect by increasing free testosterone and providing androgenic support. A second high-value use is in cutting or body recomposition cycles alongside naturally low-estrogenic compounds (Masteron, Primobolan, Anavar) where its hardening, SHBG binding, and mild anti-estrogenic effects complement the stack without adding water retention or estrogen burden. It is also genuinely useful during PCT alongside Nolvadex or Clomid for users who experience mood and libido crashes during recovery - Proviron provides androgenic support while SERMs restore LH/FSH signaling.
Proviron vs Masteron - which should I use and can they be taken together?
Proviron and Masteron share a DHT-derived structure and overlapping effects (SHBG binding, mild anti-estrogenic activity, hardening, libido support) but differ in important practical ways. Masteron (Drostanolone) is an injectable compound - Masteron Propionate requires EOD injections, Masteron Enanthate twice weekly. Proviron is oral. Masteron has meaningfully stronger androgenic and aesthetic effects - the hardening and vascularity improvement from Masteron Propionate at 300-400 mg/week is more noticeable than anything Proviron produces. Proviron is significantly cheaper and logistically simpler. Proviron's SHBG binding affinity may be somewhat higher than Masteron's at equivalent doses, and Proviron is the only choice when an injectable is not practical. They can be run together - Proviron 50 mg/day alongside Masteron in a cutting stack is a legitimate combination that reinforces SHBG binding and adds oral convenience. The choice is not either/or in most contexts: Masteron for the injectable aesthetic effect and Proviron for oral SHBG management and cycle convenience.
Related Products
- Enhances muscle hardness and definition.
- Controls estrogen to prevent gynecomastia.
- Improves libido and hormonal balance.
- Supports lean physique during cycles.
- Promotes muscle hardness and definition.
- Reduces estrogenic side effects like gynecomastia.
- Boosts libido and energy during cycles.
- Enhances effects of other anabolic steroids.
